• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » President Barack Obama signs sweeping reform law granting patent rights to first to file | MassDevice.com On Call

President Barack Obama signs sweeping reform law granting patent rights to first to file | MassDevice.com On Call

September 19, 2011 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — President Barack Obama signed the America Invents Act into law on Friday, shifting the U.S. patent reward system from one based on who first invented a product or concept to a system rewarding whoever first filed for the patent.

The law represents the biggest change to the U.S. patent reform system in decades, and has draw both adulation and ire as innovators argue that the law favors those with deep pockets over small companies or individuals.

Click here to learn more about the patent reform law with MassDevice’s podcast with patent attorney David Dykeman.

The legislation aims to get a handle on a growing tide of patent applications in limbo at the U.S. Patent & Trademark office.

"The driving force behind the whole America Invents act is that there’s a huge patent backlog of approximately 700,000 patent applications that are awaiting examination, and this typically means it takes two or three years before you hear back," Dykeman told us. "The goal is, hopefully, with better funding and more efficiency, the backlog can be decreased, patents can be issued sooner and there will be higher-quality patents."

Chronic diseases may cost $47 trillion by 2030

The World Health Organization voiced concerns that the rise of chronic diseases like diabetes, cancer, heart disease and mental illness will cost $47 trillion in productivity losses and medical treatment by 2030, Bloomberg Businessweek reported.

Baxter has a hard road ahead, analysts say

Baxter International Inc. (NYSE: BAX) has an obstacle course ahead of it after posting two strong, profitable quarters as a competing drug comes back from recall, the Chicago Tribune reported.

Lee Medical’s dialysis trays hit with Class I recall

Lee Medical International Inc. was hit with a Class I recall on concerns that PVP prep pads that come with its custom dialysis trays may not be sterile, putting patients at risk for serious infections, according to the FDA.

New device wirelessly measures surgery patient breathing

Physicians may be able to noninvasively measure breathing of surgery patients, adults with sleep apnea and babies at risk of sudden infant death syndrome suing wireless transceivers, according to a press release.

Filed Under: Food & Drug Administration (FDA), News Well, Patent Infringement, Recalls, Respiratory Tagged With: Baxter, Diseases

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy